Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Acquired by Cooper Financial Group

Cooper Financial Group boosted its position in Intuitive Surgical, Inc. (NASDAQ:ISRG) by 23.4% during the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund owned 1,059 shares of the medical equipment provider’s stock after acquiring an additional 201 shares during the quarter. Cooper Financial Group’s holdings in Intuitive Surgical were worth $553,000 as of its most recent filing with the Securities and Exchange Commission.

A number of other institutional investors have also recently added to or reduced their stakes in the company. Wedmont Private Capital grew its holdings in shares of Intuitive Surgical by 7.6% during the 4th quarter. Wedmont Private Capital now owns 6,102 shares of the medical equipment provider’s stock worth $3,341,000 after purchasing an additional 431 shares during the period. Fragasso Financial Advisors Inc lifted its position in Intuitive Surgical by 3.0% during the fourth quarter. Fragasso Financial Advisors Inc now owns 687 shares of the medical equipment provider’s stock valued at $359,000 after buying an additional 20 shares in the last quarter. Kieckhefer Group LLC acquired a new position in Intuitive Surgical during the fourth quarter valued at approximately $5,632,000. Capital Investment Advisors LLC grew its stake in Intuitive Surgical by 15.6% during the fourth quarter. Capital Investment Advisors LLC now owns 899 shares of the medical equipment provider’s stock worth $469,000 after buying an additional 121 shares during the period. Finally, Brookstone Capital Management increased its position in shares of Intuitive Surgical by 25.4% in the fourth quarter. Brookstone Capital Management now owns 18,102 shares of the medical equipment provider’s stock worth $9,448,000 after acquiring an additional 3,663 shares in the last quarter. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling

In other news, SVP Mark Brosius sold 2,128 shares of the stock in a transaction that occurred on Tuesday, October 22nd. The stock was sold at an average price of $515.00, for a total transaction of $1,095,920.00. Following the sale, the senior vice president now directly owns 273 shares in the company, valued at approximately $140,595. This represents a 88.63 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Gary S. Guthart sold 18,151 shares of the business’s stock in a transaction that occurred on Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total value of $9,286,596.13. Following the transaction, the chief executive officer now owns 24,219 shares of the company’s stock, valued at $12,391,166.97. This represents a 42.84 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 48,190 shares of company stock worth $25,012,927 over the last ninety days. 0.90% of the stock is owned by insiders.

Analyst Ratings Changes

ISRG has been the subject of a number of research reports. Royal Bank of Canada upped their price target on shares of Intuitive Surgical from $525.00 to $555.00 and gave the stock an “outperform” rating in a research report on Friday, October 18th. Leerink Partners upped their target price on Intuitive Surgical from $489.00 to $502.00 in a research report on Thursday, October 17th. Robert W. Baird raised their target price on Intuitive Surgical from $503.00 to $565.00 and gave the company an “outperform” rating in a report on Thursday, October 17th. Morgan Stanley raised Intuitive Surgical from an “equal weight” rating to an “overweight” rating and boosted their price target for the stock from $522.00 to $650.00 in a research report on Monday, December 2nd. Finally, Truist Financial increased their price objective on shares of Intuitive Surgical from $570.00 to $640.00 and gave the company a “buy” rating in a research report on Wednesday, December 18th. One investment analyst has rated the stock with a sell rating, four have assigned a hold rating and fifteen have issued a buy rating to the company’s stock. According to data from MarketBeat, Intuitive Surgical has an average rating of “Moderate Buy” and a consensus target price of $554.17.

Intuitive Surgical Stock Performance

Shares of ISRG stock opened at $539.75 on Tuesday. The stock has a market capitalization of $192.25 billion, a price-to-earnings ratio of 86.78, a PEG ratio of 5.31 and a beta of 1.39. Intuitive Surgical, Inc. has a one year low of $355.17 and a one year high of $556.23. The company’s 50-day simple moving average is $536.58 and its 200-day simple moving average is $495.83.

Intuitive Surgical (NASDAQ:ISRG) last released its earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, topping analysts’ consensus estimates of $1.24 by $0.32. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. The company had revenue of $2.04 billion for the quarter, compared to the consensus estimate of $2.01 billion. As a group, research analysts forecast that Intuitive Surgical, Inc. will post 5.45 EPS for the current year.

About Intuitive Surgical

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.